<DOC>
	<DOC>NCT01727895</DOC>
	<brief_summary>The purpose of this study is to test wether orally administered Beta-glucan has systemic effects in humans.</brief_summary>
	<brief_title>Effects of Orally Administered Beta-glucan on Leukocyte Function in Humans</brief_title>
	<detailed_description>The immunostimulatory properties of mushrooms have been recognized for centuries, and "medicinal" mushrooms are still widely used in alternative medicine all over the world. Although a number of fungal components have been implicated in these properties, Beta-glucans have attracted the most attention. However, although Beta-glucans are widely used as a health food supplement, their immunomodulatory effects after administration in humans have not yet been determined.</detailed_description>
	<mesh_term>Immunologic Deficiency Syndromes</mesh_term>
	<criteria>Written informed consent Age â‰¥18 Healthy males Subjects with a history of allergy or intolerance to Betaglucan Use of any medication Participation in a drug trial or donation of blood 3 months prior to Betaglucan administration Use of antibiotics, norit, laxatives (up till 6 months prior to inclusion), cholestyramine, acid burn inhibitors or immune suppressive agents (up till 3 months prior to inclusion), and pre and probiotics (up till 1 month prior to inclusion).</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>36 Years</maximum_age>
	<verification_date>July 2014</verification_date>
	<keyword>Betaglucan, immune modulation, immunoparalysis, immune suppression</keyword>
</DOC>